Pieris Pharmaceuticals News

Pieris Pharmaceuticals | 8-K: Current report

Apr 18 16:23 ET

Pieris Pharmaceuticals | 10-K: Annual report

Mar 29 17:33 ET

Pieris Pharmaceuticals | 8-K: Current report

Mar 27 08:04 ET

Pieris Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Aquilo Capital, L.P.(1.1%),Aquilo Capital Management, LLC(1.1%), etc.

Feb 14 16:44 ET

Pieris Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Checkpoint Capital (Master) Fund, LP(0%),Checkpoint Capital, LP(0%), etc.

Feb 14 13:18 ET

Pieris Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lynx1 Capital Management LP(9.9%),Weston Nichols(9.9%)

Feb 14 09:22 ET

Pieris Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Master Fund, L.P.(0.0%),Soleus Capital, LLC(0.0%), etc.

Feb 2 10:01 ET

Pieris Pharmaceuticals | 8-K: Current report

Dec 21, 2023 16:30 ET

Pieris Pharmaceuticals: Q3 2023 Earnings Report

Nov 14, 2023 16:02 ET

Pieris Pharmaceuticals | 8-K/A: Current report (Amendment)

Aug 31, 2023 16:15 ET

Pieris Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(20.8%),BVF Inc.(20.8%), etc.

Aug 17, 2023 16:49 ET

Pieris Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Aug 10, 2023 17:04 ET

Pieris Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

Aug 10, 2023 16:24 ET

Pieris Pharmaceuticals | 8-K: Current report

Jul 18, 2023 09:15 ET

Pieris Pharmaceuticals | 8-K: Current report

Jul 13, 2023 07:30 ET

Pieris Pharmaceuticals | 8-K: Current report

Jun 26, 2023 17:25 ET

Pieris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Barbier Ann

Jun 23, 2023 16:47 ET

Pieris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GERAGHTY JAMES A

Jun 23, 2023 16:46 ET

Pieris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kiener Peter A

Jun 23, 2023 16:46 ET

Pieris Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KIRITSY CHRISTOPHER P

Jun 23, 2023 16:46 ET